These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement]. Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859 [Abstract] [Full Text] [Related]
3. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency. Yordam N, Kandemir N, Alikaşifoğlu A. Turk J Pediatr; 1998; 40(1):55-60. PubMed ID: 9673529 [Abstract] [Full Text] [Related]
5. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M. J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209 [Abstract] [Full Text] [Related]
6. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome. Bajpai A, Kabra M, Gupta AK, Menon PS. Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678 [Abstract] [Full Text] [Related]
7. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G. Horm Res; 2009 Jul; 71(3):167-72. PubMed ID: 19188742 [Abstract] [Full Text] [Related]
10. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Zenaty D, Garel C, Limoni C, Czernichow P, Léger J. Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449 [Abstract] [Full Text] [Related]
11. An auxology-based growth hormone program: update on the Australian experience. Werther GA, Wang M, Cowell CT. J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362 [Abstract] [Full Text] [Related]
14. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma. Kedzia A, Obara-Moszyńska M, Korman E, Rabska-Pietrzak B, Kopinski P, Trojan J, Goździcka-Józefiak A. Rocz Akad Med Bialymst; 2003 May; 48():28-33. PubMed ID: 14737937 [Abstract] [Full Text] [Related]
19. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy. Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB. Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923 [Abstract] [Full Text] [Related]
20. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone. Westphal O, Lindberg A, Swedish KIGS National Board. Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]